PRLog Home
All Businesses
All Newsrooms
Press Releases Home
GTCbio
About
Newsroom
Contact
Filter By Industry
Select One
Biotech
Technology
Filter By Tag
Select One
Allergy
AMPKa Modulators
Anti-bactieral
Anti-fungal
anti-infectives Antimicrobial
Anti-m
Antibacterial
Antibiotic
Antibod
Antibodies
Antibody-drug Conjugate
Antifungal
Antiinfectives
Auto-immune Disease
Autoimmunity
Beloranib
Biomarker
Biomarker Development
Biomarker Discovery
Cancer
Cancer Drug Combinations
Cancer Drugs
Cancer Targets
Cancer Therapy
Cancer Vaccine
Cell
Chemoinformatics
Companion Diagnostics
Cross Protection
Cross Reactivity
Diabetes collaborations
Differentiation
Drug Design
embryonic stem cells Hematopoietic Stem
Fragment Based Drug Design
Fructose Bisphosphatase Inhibitors
Granulocyte
Hit And Target Identification
Induced Pluripotent
Interferon-beta
Lymphoma
Multivalent Vaccines
Oncology
Oncology Partner
Partnering
Protein-protein Interactions
Stem Cell
T-cell
Translational Medicine
Vaccines
Newsroom
GTCbio Press releases
51 - 51 of 51 Press Releases
Klaus Mendla, Global Head at Boehringer to speak at CNS Partnering meeting Sept 22-23, San Francisco
Jul 17, 2011
Klaus D. Mendla, Head of Global Business Development and Licensing CNS at Boehringer Ingelheim, to give featured presentation at 4th CNS Partnering and Deal-making Conference (Sept 22-23, 2011 in San Francisco, CA)
Page:
Prev
2
3
4
5
6
GTCbio RSS Feed
Share This Page